By 2032, sales of U.S. Digital Ovulation Test Kits Market are forecast to be worth more than US$ 162.7 million. Through 2032, the market for digital ovulation test kits is anticipated to expand at a CAGR of 9.6%. Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most …
Category Archives: Healthcare Trends
Pharmaceutical Caps and Closures Market is projected to reach US$ 4 Billion by 2032 at a CAGR of 5.7%
By the end of 2021, the Pharmaceutical Caps and Closures Market is expected to cross US$ 2.27 billion in value, according to Future Market Insights (FMI). By 2032, it is expected that the pharmaceutical caps and closures market would generate $4 billion in revenue. From 2022 to 2032, the pharmaceutical caps and closures market is …
United Kingdom Surface Disinfectants Market is projected to reach US$ 526.7 Million by 2033
The Surface Disinfectants Market is projected to generate US$ 8.1 billion in 2023. The market for surface disinfectants is projected to increase to more than US$ 16.4 billion over the next 10 years, according to Future Market Insights’ (FMI) assessment. The market was predicted to expand at a 7.3% CAGR between 2023 and 2033. The Surface …
Single Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030
A single dosage of radiation is claimed to be a safe and efficient treatment for men with low-risk prostate cancer in the Single Dose Radiotherapy Services Market since it is given directly to the tumour in a matter of minutes. Future Market Insights (FMI) predicts that by 2021, the market for single-dose therapy would have …
Continue reading “Single Dose Radiotherapy Services Market to grow at 6.1% CAGR through 2030”
APOL1 Mediated Kidney Disease Market is expected to garner a value of USD 5753.9 million and expand at a 4.3% value CAGR by 2033
The APOL1 Mediated Kidney Disease Market is anticipated to reach a worth of USD 3779.9 million in 2023 before increasing to USD 5753.9 million by 2033, with a forecasted CAGR of 4.3%. The current alternatives for treatment are few, and they only work to treat the signs of APOL1 Mediated Kidney Disease Market disorders, such …
Antibiotics Active Pharmaceutical Ingredient (API) Market | ACS DOBFAR SPA, Parabolic Drugs Ltd., Fresenius Kabi and Savior Lifetec | By 2030
FMI expects global Antibiotics Active Pharmaceutical Ingredient (API) Market demand to grow at 3.1% CAGR through 2030. Any type of surgery or long-term illness makes the patient more vulnerable to bacterial infection. The market for antibiotics API is anticipated to be driven by the rising prevalence of infections such tuberculosis, pneumonia, blood poisoning, gonorrhoea, and …
Oxytocin Market is expected to reach US$ 164.9 Million by 2030, with sales revenue expected to register 9.0% CAGR
The Oxytocin Market is anticipated to develop at a remarkable 9.0% CAGR from 2022 to 2030, reaching an estimated market value of over US$ 83.0 Million in 2022. By the end of 2030, the Oxytocin market is anticipated to reach US$ 164.9 Million. According to Future Market Insights’ predictions, Postpartum type will command a sizeable …
Heart Closure Devices Market is anticipated to reach US$ 10.88 Billion by 2033, at a CAGR 14.9%
The global Heart Closure Devices Market size is expected to be worth US$ 2.71 billion in 2023. Due to an increase in demand for highly efficient procedures among people, as well as an increase in R&D spending for developing innovative and technologically advanced products, overall demand for Heart Closure Devices is expected to grow at …
Treatment-Resistant Depression Treatment Market Share 2023 to 2033 | By Sandoz, H. Lundbeck, AbbVie, AstraZeneca
The global Treatment-Resistant Depression Treatment Market size is expected to reach US$ 1.69 billion by 2023, with a projected compound annual growth rate (CAGR) of 9.0% between 2023 and 2033, owing to the rising prevalence of depression and anxiety disorders in adults and an ageing population. By 2033, the market is estimated to be worth …
Catheter Related Bloodstream Infection Market is anticipated to reach US$ 80 billion by 2033
The global Catheter Related Bloodstream Infection (CRBSI) Market size is expected to generate a market value of US$ 44.67 billion in 2023 and a market value of US$ 80 billion by 2033, at a CAGR of 6%. The increase in the number of people suffering from urinary infections can be attributed to the growth of the Catheter-Related …